Hepatitis C virus cures after direct acting antiviral-related drug-induced liver injury: Case report

The United States Food and Drug Administration recently warned that the direct acting antiviral (DAA) combination hepatitis C virus (HCV) treatment of Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, and Ribavirin (PODr + R) can cause severe liver injury in patients with advanced liver disease. Drug...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Hepatol
Autors principals: Hasin, Yaakov, Shteingart, Shimon, Dahari, Harel, Gafanovich, Inna, Floru, Sharon, Braun, Marius, Shlomai, Amir, Verstandig, Anthony, Dery, Ilana, Uprichard, Susan L, Cotler, Scott J, Lurie, Yoav
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2016
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4945506/
https://ncbi.nlm.nih.gov/pubmed/27458506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v8.i20.858
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars